Brief: Ultimovacs Gets EMA Orphan Drug Designation For Uv1 Cancer Vaccine For Treatment Of Mesothelioma

Zelluna ASA

19/02/2024 06:24

Feb 19 (Reuters) - Ultimovacs ASA  ULTI.OL :
    * RECEIVES EMA ORPHAN DRUG DESIGNATION FOR UV1 CANCER
VACCINE FOR
THE TREATMENT OF MESOTHELIOMA

Source text for Eikon:  ID: 
Further company coverage:  ULTI.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))